phosphoserine has been researched along with Pseudohypoaldosteronism in 1 studies
Phosphoserine: The phosphoric acid ester of serine.
Pseudohypoaldosteronism: A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CastaƱeda-Bueno, M | 1 |
Arroyo, JP | 1 |
Zhang, J | 1 |
Puthumana, J | 1 |
Yarborough, O | 1 |
Shibata, S | 1 |
Rojas-Vega, L | 1 |
Gamba, G | 1 |
Rinehart, J | 1 |
Lifton, RP | 1 |
1 other study available for phosphoserine and Pseudohypoaldosteronism
Article | Year |
---|---|
Phosphorylation by PKC and PKA regulate the kinase activity and downstream signaling of WNK4.
Topics: Angiotensin II; Animals; Blood Volume; Chlorocebus aethiops; COS Cells; Cyclic AMP-Dependent Protein | 2017 |